Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? a meta-analysis

HIGHLIGHTS

• who: Lingbo Hu from the , China have published the research: Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis, in the Journal: (JOURNAL) of January/26,/2023
• what: The analysis demonstrated that patients with HCC could benefit from HAIC in the short term and that HCC patients with PVI or MVI benefit from HAIC in the long term.
• how: Quality assessment and data extraction Initial assessment of the quality of each study and the following data extraction were conducted independently by two researchers (LB . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.